 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | ANPD001 / Aspen Neurosci
New P1 trial: ASPERO: Phase 1/2a Study of ANPD001 in Parkinson Disease (clinicaltrials.gov) - Apr 3, 2024
P1, N=9, Enrolling by invitation, Sponsor: Aspen Neuroscience